Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

3D Bioprinting Market Analysis (2016-2021) - Expected to be Worth $10 Billion by 2020 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "3D Bioprinting Market Analysis - With Forecast (2016-2021)" report to their offering.

3D bioprinting is a technique by which viable cells and tissues are printed in 3D in a controlled environment, and the final product can be used to a certain extent as a replacement for actual tissue. The technology is still very much in the nascent stages; however, it will soon be in a position to be commercialized on a large scale by the end of 2020. There are already a number of research centers that are experimenting with the technology today and a number of research departments of various universities that are investing in the research of this technology.

The applications for bioprinting are many ranging from the obvious healthcare industry to the cosmetic industry. Bioprinting will be able to provide replacement tissue for burn victims or anyone that needs a skin graft and can also provide certain slices of internal organ tissue.

Looking at the cosmetic industry, this industry has always been infamous for testing on animals many of their products which include deodorants, lipstick, make-up and so on. The testing is done on animals to see what the side effects are and only then are these products made available. Through bioprinting, the testing can be done on skin that is printed and would provide the companies a better subject for testing rather than always looking at animals.

Although the market is still in the early stages, it its expected to be worth more than $10 billion by the end of 2020. The healthcare industry alone will be able to utilize this technology completely for R&D purposes as well.

Companies Mentioned:

  • 3D Biotek
  • 3D Systems
  • Advanced Biomatrix
  • Autodesk
  • Avita Medical
  • BD Biosciences
  • Bespoke Innovations
  • Bio3D Technologies
  • (10+ Others)

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. By Type

7. By Application

8. By Geography

9. Market Entropy

10. Company Profiles

11. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/ncgm7t/3d_bioprinting

Related Topics: 3D Printing

View source version on businesswire.com: http://www.businesswire.com/news/home/20160825005888/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.